These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29208618)

  • 21. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylphenidate as Needed for Fatigue in Patients With Advanced Cancer. A Prospective, Double-Blind, and Placebo-Controlled Study.
    Pedersen L; Lund L; Petersen MA; Sjogren P; Groenvold M
    J Pain Symptom Manage; 2020 Nov; 60(5):992-1002. PubMed ID: 32464260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of methylphenidate to relieve fatigue.
    Rojí R; Centeno C
    Curr Opin Support Palliat Care; 2017 Dec; 11(4):299-305. PubMed ID: 28885263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment.
    Miladinia M; Jahangiri M; White SJ; Karimpourian H; Inno A; Chan SW; Ganji R; Maniati M; Zarea K; Ghalamkari M; Farahat A; Fagerström C
    Trials; 2024 Apr; 25(1):230. PubMed ID: 38570861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with response to methylphenidate in advanced cancer patients.
    Yennurajalingam S; Palmer JL; Chacko R; Bruera E
    Oncologist; 2011; 16(2):246-53. PubMed ID: 21282671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
    Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
    J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer.
    Johnson RL; Block I; Gold MA; Markwell S; Zupancic M
    Psychooncology; 2010 Sep; 19(9):955-8. PubMed ID: 19918954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial.
    Jopson L; Newton JL; Palmer J; Floudas A; Isaacs J; Qian J; Wilkinson J; Trenell M; Blamire A; Howel D; Jones DE
    BMJ Open; 2015 Aug; 5(8):e007985. PubMed ID: 26297361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sipjeondaebo-tang in patients with breast cancer with fatigue: a protocol for a pilot, randomised, double-blind, placebo-controlled, cross-over trial.
    Cheon C; Kang S; Ko Y; Kim M; Jang BH; Shin YC; Ko SG
    BMJ Open; 2018 Jul; 8(7):e021242. PubMed ID: 29982213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
    Lower EE; Malhotra A; Surdulescu V; Baughman RP
    J Pain Symptom Manage; 2013 Feb; 45(2):159-69. PubMed ID: 22917711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.
    Yennurajalingam S; Carmack C; Balachandran D; Eng C; Lim B; Delgado M; Guzman Gutierrez D; Raznahan M; Park M; Hess KR; Williams JL; Lu Z; Ochoa J; Bruera E
    BMJ Support Palliat Care; 2021 Jun; 11(2):170-179. PubMed ID: 31924662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.
    Escalante CP; Meyers C; Reuben JM; Wang X; Qiao W; Manzullo E; Alvarez RH; Morrow PK; Gonzalez-Angulo AM; Wang XS; Mendoza T; Liu W; Holmes H; Hwang J; Pisters K; Overman M; Cleeland C
    Cancer J; 2014; 20(1):8-14. PubMed ID: 24445757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modafinil for the treatment of fatigue in lung cancer: a pilot study.
    Spathis A; Dhillan R; Booden D; Forbes K; Vrotsou K; Fife K
    Palliat Med; 2009 Jun; 23(4):325-31. PubMed ID: 19270033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of methylphenidate for the management of fatigue in Chinese patients with cancer.
    Siu SW; Law M; Liu RK; Wong KH; Soong IS; Kwok AO; Ng KH; Lam PT; Leung TW
    Am J Hosp Palliat Care; 2014 May; 31(3):281-6. PubMed ID: 23650644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study.
    Sugawara Y; Akechi T; Shima Y; Okuyama T; Akizuki N; Nakano T; Uchitomi Y
    Palliat Med; 2002 May; 16(3):261-3. PubMed ID: 12047006
    [No Abstract]   [Full Text] [Related]  

  • 36. Methylphenidate for fatigue in ambulatory men with prostate cancer.
    Roth AJ; Nelson C; Rosenfeld B; Scher H; Slovin S; Morris M; O'Shea N; Arauz G; Breitbart W
    Cancer; 2010 Nov; 116(21):5102-10. PubMed ID: 20665492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of methylphenidate in patients with cancer.
    Sood A; Barton DL; Loprinzi CL
    Am J Hosp Palliat Care; 2006; 23(1):35-40. PubMed ID: 16450661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.
    Minton O; Richardson A; Sharpe M; Hotopf M; Stone P
    J Natl Cancer Inst; 2008 Aug; 100(16):1155-66. PubMed ID: 18695134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Question 1: Is methylphenidate a useful treatment for cancer-related fatigue in children?
    Sharp V; Finlay F; Kevitiyagala D
    Arch Dis Child; 2013 Jan; 98(1):80-2. PubMed ID: 23255040
    [No Abstract]   [Full Text] [Related]  

  • 40. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.
    Ravindran AV; Kennedy SH; O'Donovan MC; Fallu A; Camacho F; Binder CE
    J Clin Psychiatry; 2008 Jan; 69(1):87-94. PubMed ID: 18312042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.